The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Financials pace gains as Footsie keeps climbing

Mon, 20th Jun 2016 12:29

(ShareCast News) - Stocks in London were continuing to move higher come midday on Monday, alongside the largest gain the pound in three months, with investors taking their cue from strong gains in Asia as Brexit polls showed the Remain campaign was in the lead.As of 12:03 BST, the FTSE 100 was 183.60 points or 3.05% higher at 6,204.69, led higher by gains in financials such as Hargreaves Lansdown and RBS together with housebuilders, including Taylor Wimpey and Barratt Developments.Against the US dollar, the pound was gaining 1.84% to 1.4629. In parallel, front month Brent crude futures gained 1.64% to $49.99 per barrel on the ICE. Three-month LME-traded copper futures on the other hand were down by 1.2% to $4,552 per metric tonne.Over the weekend, a Survation poll in the Daily Mail revealed that support for the 'Remain' campaign was in the lead at 45.0% versus 42.0% for 'Leave', while two YouGov polls - one for ITV's Good Morning Britain and one for the Sunday Times - both showed Remain in front.In addition, a ComRes poll for the Sunday Mirror revealed the percentage of people saying they'd be relieved if the UK stayed in the EU rose to 45% after the murder of MP Jox Cox, from 35% before.Meanwhile, an opinion survey conducted for the Observer between Tuesday and Friday showed an even split but of the 10% undecided, 36% said they were leaning towards Remain.According to Oddschecker's tally of the odds being offered by bookmakers, the chances of 'Remain' coming out on top were being put at 31%, down from a record 44.0% just before the killing of lawmaker Jo Cox."We're still getting some rather ludicrous predictions of what the pound might do in the event of a "leave" vote, which to some extent has caused some rather extreme positioning, and will likely contribute to a lot more choppiness in the coming days, as this morning's Asia surge catches an awful lot of people the wrong way round," said Michael Hewson, chief market analyst at CMC Markets UK.BT Group, TalkTalk jump"With growing mobile data usage, we see mobile as an essential utility," UBS analyst Polo Tang said in a research note sent to clients. In case of 'Bremain', Tang expected a rebound in the likes of Sky, BT and TalkTalk. Those UK-centric three names had already underperformed going into the EU referendum (although they were relatively resilient operationally in the last downturn), he said.Heavily indebted North Sea oil producer EnQuest has denied media reports that it is in talks with the UK Oil and Gas Authority (OAG) about contingency plans. The government body fears insolvencies at Enquest and mid-cap peer Premier Oil, the Sunday Telegraph reported, and is mulling plans "to guard against a North Sea bankruptcy crisis" as the pair are "wracked with debt following the oil market rout and now stand at the mercy of their lenders".Gemfields, a British supplier of responsibly sourced coloured gemstones, reported record total revenues of $44.3m at a recent auction of rough rubies in Singapore as the increasing quality of Mozambique gems attracts growing demand.Shares in biopharmaceutical development company Circassia Pharmaceuticals plummeted on Monday morning, after it announced disappointing top-line results from its investigational cat allergy immunotherapy phase III study.Hammerson said it has exchanged contracts and completed the sale of Thurrock Shopping Park, Essex, to TH Real Estate for £93m. The sale price represents a net initial yield of 5.3% and is moderately below the book value as at 31 December 2015, Hammerson said.Late-stage drug trials by GlaxoSmithKline on its treatment for chronic obstructive pulmonary disease (COPD) have proved successful. The Phase III clinical testing by GSK and project partner Innoviva delivered data that is likely to support European regulatory submission by the end of 2016.FTSE 250 precision instruments maker Spectris has completed the acquisition of the software and associated assets of privately-held software solutions company Capstone Technology Corp for $22.5m. Capstone comprises two key software platforms: the MACS software suite providing engineering services and software for advanced process control optimisation and dataPARC, which is a data historian, visualisation and analytics software suite for operational decision support.Market MoversFTSE 100 (UKX) 6,216.27 3.24%FTSE 250 (MCX) 16,904.12 2.94%techMARK (TASX) 3,060.79 3.20%FTSE 100 - RisersHargreaves Lansdown (HL.) 1,320.00p 7.40%Royal Bank of Scotland Group (RBS) 238.40p 7.34%Taylor Wimpey (TW.) 187.80p 6.70%Worldpay Group (WI) (WPG) 291.70p 6.50%Barratt Developments (BDEV) 566.00p 6.49%Lloyds Banking Group (LLOY) 69.26p 6.47%St James's Place (STJ) 875.50p 6.25%Barclays (BARC) 175.95p 6.15%Aviva (AV.) 431.40p 6.02%International Consolidated Airlines Group SA (CDI) (IAG) 505.50p 5.69%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 6,445.00p -2.50%Fresnillo (FRES) 1,213.00p -1.14%Rexam (REX) 627.50p -0.32%SABMiller (SAB) 4,288.00p 0.76%Rio Tinto (RIO) 2,028.00p 1.12%Antofagasta (ANTO) 431.30p 1.75%Hikma Pharmaceuticals (HIK) 2,189.00p 2.00%HSBC Holdings (HSBA) 440.25p 2.10%National Grid (NG.) 979.00p 2.11%BHP Billiton (BLT) 848.40p 2.12%FTSE 250 - RisersEvraz (EVR) 118.60p 8.71%Paragon Group Of Companies (PAG) 294.30p 6.82%Greggs (GRG) 1,089.00p 6.66%St. Modwen Properties (SMP) 318.40p 6.38%AA (AA.) 279.80p 6.27%Bovis Homes Group (BVS) 986.50p 6.25%Bellway (BWY) 2,711.00p 6.23%Serco Group (SRP) 109.60p 6.10%Unite Group (UTG) 640.50p 6.04%Virgin Money Holdings (UK) (VM.) 342.70p 6.03%FTSE 250 - FallersCircassia Pharmaceuticals (CIR) 96.75p -64.21%Centamin (DI) (CEY) 109.10p -1.89%Acacia Mining (ACA) 330.90p -1.63%Allied Minds (ALM) 330.00p -1.29%Templeton Emerging Markets Inv Trust (TEM) 459.40p -0.73%P2P Global Investments (P2P) 844.00p -0.65%BH Macro Ltd. GBP Shares (BHMG) 1,939.00p -0.41%Riverstone Energy Limited (RSE) 866.50p -0.40%Vectura Group (VEC) 156.60p -0.25%IP Group (IPO) 167.20p -0.18%
More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.